440 related articles for article (PubMed ID: 29769270)
21. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector.
Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R
BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563
[TBL] [Abstract][Full Text] [Related]
22. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
23. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
Cervantes-Barragán L; Gil-Cruz C; Pastelin-Palacios R; Lang KS; Isibasi A; Ludewig B; López-Macías C
Eur J Immunol; 2009 Jan; 39(1):126-35. PubMed ID: 19130558
[TBL] [Abstract][Full Text] [Related]
24. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
25. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.
Dadaglio G; Fayolle C; Zhang X; Ryffel B; Oberkampf M; Felix T; Hervas-Stubbs S; Osicka R; Sebo P; Ladant D; Leclerc C
J Immunol; 2014 Aug; 193(4):1787-98. PubMed ID: 25024388
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice.
Lumsden JM; Nurmukhambetova S; Klein JH; Sattabongkot J; Bennett JW; Bertholet S; Fox CB; Reed SG; Ockenhouse CF; Howard RF; Polhemus ME; Yadava A
Vaccine; 2012 May; 30(22):3311-9. PubMed ID: 22425788
[TBL] [Abstract][Full Text] [Related]
27. The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling.
Desel C; Werninghaus K; Ritter M; Jozefowski K; Wenzel J; Russkamp N; Schleicher U; Christensen D; Wirtz S; Kirschning C; Agger EM; Prazeres da Costa C; Lang R
PLoS One; 2013; 8(1):e53531. PubMed ID: 23308247
[TBL] [Abstract][Full Text] [Related]
28. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome.
Shenderov K; Barber DL; Mayer-Barber KD; Gurcha SS; Jankovic D; Feng CG; Oland S; Hieny S; Caspar P; Yamasaki S; Lin X; Ting JP; Trinchieri G; Besra GS; Cerundolo V; Sher A
J Immunol; 2013 Jun; 190(11):5722-30. PubMed ID: 23630357
[TBL] [Abstract][Full Text] [Related]
29. Inflammasome and Fas-Mediated IL-1β Contributes to Th17/Th1 Cell Induction in Pathogenic Bacterial Infection In Vivo.
Uchiyama R; Yonehara S; Taniguchi S; Ishido S; Ishii KJ; Tsutsui H
J Immunol; 2017 Aug; 199(3):1122-1130. PubMed ID: 28674179
[TBL] [Abstract][Full Text] [Related]
30. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome.
Rabeony H; Pohin M; Vasseur P; Petit-Paris I; Jégou JF; Favot L; Frouin E; Boutet MA; Blanchard F; Togbe D; Ryffel B; Bernard FX; Lecron JC; Morel F
Eur J Immunol; 2015 Oct; 45(10):2847-57. PubMed ID: 26147228
[TBL] [Abstract][Full Text] [Related]
31. Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice.
Imamura M; Tsutsui H; Yasuda K; Uchiyama R; Yumikura-Futatsugi S; Mitani K; Hayashi S; Akira S; Taniguchi S; Van Rooijen N; Tschopp J; Yamamoto T; Fujimoto J; Nakanishi K
J Hepatol; 2009 Aug; 51(2):333-41. PubMed ID: 19501931
[TBL] [Abstract][Full Text] [Related]
32. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome.
Ren R; Wu S; Cai J; Yang Y; Ren X; Feng Y; Chen L; Qin B; Xu C; Yang H; Song Z; Tian D; Hu Y; Zhou X; Meng G
Sci Rep; 2017 Aug; 7(1):7625. PubMed ID: 28790324
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection.
Omosun Y; McKeithen D; Ryans K; Kibakaya C; Blas-Machado U; Li D; Singh R; Inoue K; Xiong ZG; Eko F; Black C; Igietseme J; He Q
Infect Immun; 2015 Dec; 83(12):4662-72. PubMed ID: 26371131
[TBL] [Abstract][Full Text] [Related]
34. The importance of adjuvant formulation in the development of a tuberculosis vaccine.
Baldwin SL; Bertholet S; Reese VA; Ching LK; Reed SG; Coler RN
J Immunol; 2012 Mar; 188(5):2189-97. PubMed ID: 22291184
[TBL] [Abstract][Full Text] [Related]
35. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity.
Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR
J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281
[TBL] [Abstract][Full Text] [Related]
36. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
[TBL] [Abstract][Full Text] [Related]
37. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Schweneker K; Gorka O; Schweneker M; Poeck H; Tschopp J; Peschel C; Ruland J; Gross O
Immunobiology; 2013 Apr; 218(4):664-73. PubMed ID: 22921586
[TBL] [Abstract][Full Text] [Related]
38. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
39. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.
George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S
Front Immunol; 2022; 13():961094. PubMed ID: 36119026
[No Abstract] [Full Text] [Related]
40. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
